Pier Capital’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-82,480
| Closed | -$2.57M | – | 137 |
|
|
2024
Q3 | $2.57M | Buy |
82,480
+1,174
| +1% | +$36.5K | 0.36% | 97 |
|
|
2024
Q2 | $2.76M | Sell |
81,306
-6,748
| -8% | -$229K | 0.41% | 95 |
|
|
2024
Q1 | $5.72M | Buy |
88,054
+1,852
| +2% | +$120K | 0.79% | 63 |
|
|
2023
Q4 | $5.89M | Sell |
86,202
-1,220
| -1% | -$83.4K | 0.84% | 63 |
|
|
2023
Q3 | $4.54M | Buy |
87,422
+19,135
| +28% | +$993K | 0.73% | 70 |
|
|
2023
Q2 | $4.09M | Sell |
68,287
-257
| -0.4% | -$15.4K | 0.59% | 83 |
|
|
2023
Q1 | $3.39M | Sell |
68,544
-189
| -0.3% | -$9.34K | 0.51% | 92 |
|
|
2022
Q4 | $3.92M | Sell |
68,733
-973
| -1% | -$55.5K | 0.64% | 75 |
|
|
2022
Q3 | $3.27M | Sell |
69,706
-53,688
| -44% | -$2.52M | 0.56% | 82 |
|
|
2022
Q2 | $4.6M | Sell |
123,394
-113,222
| -48% | -$4.22M | 0.79% | 68 |
|
|
2022
Q1 | $7.08M | Sell |
236,616
-1,160
| -0.5% | -$34.7K | 0.9% | 65 |
|
|
2021
Q4 | $8.14M | Buy |
237,776
+159,262
| +203% | +$5.45M | 0.86% | 67 |
|
|
2021
Q3 | $2.91M | Buy |
+78,514
| New | +$2.91M | 0.3% | 98 |
|